KRAS and neoplasm: Previous research has demonstrated that tumor microenvironment (such as hypoxia), numerous growth factors, and carcinogenic-associated signaling pathways (such as TGF-β, Notch, MAPK, and KRAS signaling pathways), can activate the EMT process (42–44).